Jelena Vukasinovic
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$7.2MFederal grants as PI12 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
12 awards · $7.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 7, 2025 | NIH | SBIR Phase II An integrated MPS platform with "virtual humans" for chemical toxicity testing | $1.1M | LENA BIOSCIENCES, INC. |
| Aug 22, 2024 | NIH | SBIR Phase II An integrated MPS platform with "virtual humans" for chemical toxicity testing | $901K | LENA BIOSCIENCES, INC. |
| May 6, 2024 | NIH | SBIR Phase II Perfused organ panel as an animal surrogate for chemical toxicity testing | $923K | LENA BIOSCIENCES, INC. |
| May 8, 2023 | NIH | SBIR Phase II Perfused organ panel as an animal surrogate for chemical toxicity testing | $881K | LENA BIOSCIENCES, INC. |
| Apr 22, 2023 | NIH | SBIR Phase I A microphysiological system with a synthetic hemoglobin, Blood Substitute, for mechanistic assessment of drug-induced liver injury | $79K | LENA BIOSCIENCES, INC. |
| Jun 1, 2022 | NIH | SBIR Phase I A microphysiological system with a synthetic hemoglobin, Blood Substitute, for mechanistic assessment of drug-induced liver injury | $300K | LENA BIOSCIENCES, INC. |
| Aug 1, 2020 | NIH | SBIR Phase I Perfused organ panel as an animal surrogate for chemical toxicity testing | $252K | LENA BIOSCIENCES, INC. |
| Jul 10, 2019 | NIH | SBIR Phase II Tools for drug efficacy studies in perfused tissue models | $722K | LENA BIOSCIENCES, INC. |
| Jul 1, 2018 | NIH | SBIR Phase II Tools for drug efficacy studies in perfused tissue models | $1.4M | LENA BIOSCIENCES, INC. |
| May 1, 2016 | NIH | SBIR Phase I Tools for drug efficacy studies in perfused tissue models | $325K | LENA BIOSCIENCES, INC. |
| 2016 | NSF | SBIR Phase I SBIR Phase I: Clinical-Trials-on-a-Chip | $150K | LENA BIOSCIENCES, INC. |
| Dec 1, 2015 | NSF | SBIR Phase I SBIR Phase I: Clinical-Trials-on-a-Chip | $150K | LENA BIOSCIENCES, INC. |
Peer ranks
Federal funding#140
Awards as PI#97
Patents#505
Companies
- LENA BIOSCIENCES, INC.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.